Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12

AIM: To gather data on the antiviral efficacy and safety of second generation direct acting antiviral (DAA) treatment with respect to sustained virological response (SVR) 12 wk after conclusion of treatment, and to determine predictors of SVR12 in this setting. METHODS: Two hundred and sixty patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Christoph R, Schwarz, Julia M, Egetemeyr, Daniel P, Beck, Robert, Malek, Nisar P, Lauer, Ulrich M, Berg, Christoph P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028818/
https://www.ncbi.nlm.nih.gov/pubmed/27672299
http://dx.doi.org/10.3748/wjg.v22.i35.8050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028818/
https://www.ncbi.nlm.nih.gov/pubmed/27672299
http://dx.doi.org/10.3748/wjg.v22.i35.8050

Ejemplares similares